Aura Biosciences revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AURA annual revenue was $0.0, with N/A growth year-over-year.
AURA revenue history
Current Revenue
$0.0
Current Earnings
-$86.9M
Current Profit Margin
0%
Be the first to know when AURA announces revenue.
AURA Revenue History By Year
AURA Yearly Revenue
AURA Revenue
AURA Change
AURA Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
2019-12-31
$0.00
N/A
N/A
1 of 1
Aura Biosciences Revenue FAQ
What was AURA's revenue last quarter?
Aura Biosciences (NASDAQ: AURA) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Aura Biosciences's revenue was $0.00.
What was Aura Biosciences's revenue in 2024?
Aura Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Aura Biosciences make in a day?
Based on Aura Biosciences annual revenue for the past five years, AURA makes an average of $0.00 per day.
What was Aura Biosciences's annual revenue growth in the past year?
As of Q2 2025, Aura Biosciences's revenue has grown null year over year. Aura Biosciences's revenue in the past year totaled $0.00.
How much does Aura Biosciences make in a year?
Aura Biosciences's revenue by year for the past five years is:
Aura Biosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Aura Biosciences's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Aura Biosciences's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Aura Biosciences's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Aura Biosciences's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.